Additional Surgical Intervention after Radical Prostatectomy, Radiation Therapy, Androgen-Deprivation Therapy, or Watchful Waiting

European Urology

Volumn 52, Issue 4, 2007, Pages 1036-1043

  Berge, Viktor ^a   Thompson, Trevor ^b   Blackman, Donald ^b  

^a AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Additional surgical intervention; Androgen deprivation therapy; Prostate cancer; Radiation therapy; Radical prostatectomy; Watchful waiting

Indexed keywords

ARTICLE; BLADDER IRRIGATION; BLADDER NECK; BLADDER SPHINCTER PROSTHESIS; BLADDER SURGERY; CANCER PATIENT; CANCER STAGING; CYSTOSCOPY; HUMAN; MEN'S HEALTH; NEPHROSTOMY; PATIENT MONITORING; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; TRANSURETHRAL RESECTION;

AGED; ANDROGEN ANTAGONISTS; COHORT STUDIES; COMBINED MODALITY THERAPY; COMORBIDITY; HUMANS; LONGITUDINAL STUDIES; MALE; NATIONAL CANCER INSTITUTE (U.S.); NEOPLASM STAGING; PROSTATECTOMY; PROSTATIC NEOPLASMS; UNITED STATES;

EID: 34548285458     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.12.012     Document Type: Article

References (16)

1. Benoit R.M., Naslund M.J., and Cohen J.K. Complications after radical retropubic prostatectomy in the Medicare population. Urology 56 (2000) 116-120
2. Lilleby W., Fossa S.D., Waehre H.R., et al. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Rad Onc Bio Phys 43 (1999) 735-743
3. Gardner B.G., Zietman A.L., Shipley W.U., et al. Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167 (2002) 123-126
4. Brasso K., Friis S., Juel K., et al. The need for hospital care of patients with clinically localized prostate cancer managed by noncurative intent: a population based registry study. J Urol 163 (2000) 1150-1154
5. Otnes B., Harvei S., and Fosså S.D. The burden of prostate cancer from diagnosis until death. Br J Urol 76 (1995) 587-594
6. Aus G., Hugosson J., and Norlen L. Need for hospital care and palliative treatment for prostate cancer treated with noncurrative intent. J Urol 154 (1995) 466-469
7. Potosky A.L., Warren J.L., Riedel E.R., et al. Measuring complications of cancer treatment using SEER-Medicare data. Med Care 40 suppl 8 (2002) IV-62-IV-68
8. SEER Registries. Information available at URL: http://seer.cancer.gov/registries.
9. SEER-Medicare Linked Database. Information available at URL: http://healthservices.cancer.gov/seermedicare.
10. American Joint Committee on Cancer. In: Beahrs O.H., Henson D.E., Hutter R.V.P., et al. (Eds). Manual for staging of cancer. 4th ed. (1992), JB Lippincott Company, Philadelphia
11. SEER extent of disease-1988. Codes and coding instructions. 2nd ed. Bethesda (MD): National Institutes of Health, National Cancer Institute; 1992. NIH pub no. 92-2313.
12. Lu-Yao G.L., Potosky A.L., Albertsen P.C., et al. Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. J Natl Cancer Inst 88 (1996) 166-173
13. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
14. Klabunde C.N., Potosky A.L., Legler J.M., et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 53 (2000) 1258-1267
15. Berge V, Thompson T, Blackman D. Use of additional prostate cancer treatment after initial radical prostatectomy, radiation therapy, androgen deprivation therapy or watchful waiting. Scan J Urol Nephrol. In press.
16. The Medical Research Council Prostate Cancer Working Party Investigators Group. Immediate versus deferred treatment for advanced prostatic cancer: initial results of the Medical Research Council trial. Br J Urol 79 (1997) 235-246